View in EDS

CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells.

Saved in:
Bibliographic Details
Title: CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells.
Authors: Lopes R; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Korkmaz G; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Revilla SA; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Vliet R; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Nagel R; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Custers L; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Kim Y; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Breugel PC; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Moumbeini B; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Manber Z; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel., Elkon R; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel., Agami R; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands. Electronic address: r.agami@nki.nl.
Source: Cancer letters [Cancer Lett] 2018 Nov 01; Vol. 436, pp. 87-95. Date of Electronic Publication: 2018 Aug 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30145202
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lopes+R%22">Lopes R</searchLink>; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Korkmaz+G%22">Korkmaz G</searchLink>; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Revilla+SA%22">Revilla SA</searchLink>; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Vliet+R%22">van Vliet R</searchLink>; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Nagel+R%22">Nagel R</searchLink>; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Custers+L%22">Custers L</searchLink>; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kim+Y%22">Kim Y</searchLink>; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Breugel+PC%22">van Breugel PC</searchLink>; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Zwart+W%22">Zwart W</searchLink>; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Moumbeini+B%22">Moumbeini B</searchLink>; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Manber+Z%22">Manber Z</searchLink>; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel.<br /><searchLink fieldCode="AU" term="%22Elkon+R%22">Elkon R</searchLink>; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel.<br /><searchLink fieldCode="AU" term="%22Agami+R%22">Agami R</searchLink>; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands. Electronic address: r.agami@nki.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227600053%22">Cancer letters</searchLink> [Cancer Lett] 2018 Nov 01; Vol. 436, pp. 87-95. <i>Date of Electronic Publication: </i>2018 Aug 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ireland%22">Elsevier Science Ireland </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>7600053 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7980 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203043835%22">03043835 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Lett <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30145202
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.canlet.2018.08.018
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 87
    Titles:
      – TitleFull: CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lopes R
      – PersonEntity:
          Name:
            NameFull: Korkmaz G
      – PersonEntity:
          Name:
            NameFull: Revilla SA
      – PersonEntity:
          Name:
            NameFull: van Vliet R
      – PersonEntity:
          Name:
            NameFull: Nagel R
      – PersonEntity:
          Name:
            NameFull: Custers L
      – PersonEntity:
          Name:
            NameFull: Kim Y
      – PersonEntity:
          Name:
            NameFull: van Breugel PC
      – PersonEntity:
          Name:
            NameFull: Zwart W
      – PersonEntity:
          Name:
            NameFull: Moumbeini B
      – PersonEntity:
          Name:
            NameFull: Manber Z
      – PersonEntity:
          Name:
            NameFull: Elkon R
      – PersonEntity:
          Name:
            NameFull: Agami R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2018 Nov 01
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1872-7980
          Numbering:
            – Type: volume
              Value: 436
          Titles:
            – TitleFull: Cancer letters
              Type: main
ResultId 1